Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3653921011 | Product containing halobetasol (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3715088019 | Halobetasol-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing halobetasol | Is a | Product containing glucocorticoid | true | Inferred relationship | Existential restriction modifier | ||
| Product containing halobetasol | Has active ingredient | Halobetasol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing halobetasol | Is a | Product containing fluorinated corticosteroid | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely halobetasol propionate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) | Is a | False | Product containing halobetasol | Inferred relationship | Existential restriction modifier | |
| Product containing only halobetasol (medicinal product) | Is a | True | Product containing halobetasol | Inferred relationship | Existential restriction modifier | |
| Product containing halobetasol in cutaneous dose form (medicinal product form) | Is a | True | Product containing halobetasol | Inferred relationship | Existential restriction modifier | |
| Product containing halobetasol and tazarotene (medicinal product) | Is a | True | Product containing halobetasol | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR